Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation

Affiliations

Xiang Yang: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Hongxiao Wang: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Enjun Xie: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Biyao Tang: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Qingdian Mu: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Zijun Song: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Junyi Chen: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Fudi Wang: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine
Junxia Min: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine

Abstract

No abstracts available.

ISSN: 1674-800X (Print); 1674-8018 (Online)
Publisher: Oxford University Press
Country of publisher: United Kingdom
LCC subjects: Science: Biology (General): Cytology; Science: Physiology: Animal biochemistry
Website: https://academic.oup.com/proteincell